Sergio Piñeiro-Hermida

6PUBLICATIONS
15CO-AUTHORS
Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 21, 2023
Telomerase deficiency and dysfunctional telomeres in the lung tumor microenvironment impair tumor progression in NSCLC mouse models and patient-derived xenografts.

Sergio Piñeiro-Hermida, Giuseppe Bosso, Raúl Sánchez-Vázquez

|Apr 23, 2022
CAR-T Cells for the Treatment of Lung Cancer.

Luisa Chocarro, Hugo Arasanz, Leticia Fernández-Rubio

|Apr 23, 2022
Correction: Alfaro-Arnedo et al. IGF1R as a Potential Pharmacological Target in Allergic Asthma. Biomedicines 2021, 9, 912.

Elvira Alfaro-Arnedo, Icíar P López, Sergio Piñeiro-Hermida

|Aug 27, 2021
IGF1R as a Potential Pharmacological Target in Allergic Asthma.

Elvira Alfaro-Arnedo, Icíar P López, Sergio Piñeiro-Hermida

|May 04, 2021
Short and dysfunctional telomeres protect from allergen-induced airway inflammation.

Sergio Piñeiro-Hermida, Paula Martínez, Maria A Blasco

|Feb 10, 2021
IGF1R Deficiency Modulates Brain Signaling Pathways and Disturbs Mitochondria and Redox Homeostasis.

Susana Cardoso, Icíar P López, Sergio Piñeiro-Hermida

Pageof 1